2017 Clinical Conference Evaluation & Post Test-Enduring Materials Format: Fatty Liver Disease

OCT 17, 2017- EVALUATION Oct 17 2017- Evaluation - Fatty Liver Disease, - Rishi Sharma MD
ESTIMATED TIME TO COMPLETE THE ACTIVITY IS 45 MINUTES. ACTIVITY AND CONTENT EXPIRES: 10-10-2020
STATEMENT OF DISCLOSURE: THE PLANNERS AND FACULTY FOR THIS ACTIVITY HAVE NO RELEVANT FINANCIAL RELATIONSHIPS WITH COMMERCIAL INTERESTS. NO OTHERS INDIVIDUALS INVOLVED IN THE PLANNING OR PRESENTATION OF THIS ACTIVITY HAVE ANY RELEVANT FINANCIAL RELATIONSHIPS WITH COMMERCIAL INTERESTS TO DISCLOSE.
ACCREDITATION STATEMENT: JOHN MUIR HEALTH IS ACCREDITED BY THE INSTITUTE FOR MEDICAL QUALITY/CALIFORNIA MEDICAL ASSOCIATION (IMQ/CMA) TO PROVIDE CONTINUING MEDICAL EDUCATION FOR PHYSICIANS.
CREDIT DESIGNATION STATEMENT: JOHN MUIR HEALTH DESIGNATES THIS ENDURING MATERIAL FOR A MAXIMUM OF ONE (.75) AMA PRA CATEGORY 1 CREDITS™. PHYSICIANS SHOULD CLAIM ONLY THE CREDIT COMMENSURATE WITH THE EXTENT OF THEIR PARTICIPATION IN THE ACTIVITY.
MINIMUM LEVEL OF ACHIEVEMENT: MUST SCORE 75% CORRECT ON POSTTEST AND COMPLETE THE STATEMENT OF HOW YOU WILL IMPROVE YOUR PRACTICE AFTER PARTICIPATION IS MANDATORY.
JMH INTERNET POLICY: HTTPS://WWW.JOHNMUIRHEALTH.COM/WEBSITE-PRIVACY-POLICY1.HTML

1. Physician Info

Physician First Name

Physician Last Name

2. Date of Completion? This question requires a valid date format of MM/DD/YYYY.

calendar

3. As a result of attending this CME activity, which of these do you plan to implement and/or change in your practice? *This question is required.

Space Cell	Definitely	Maybe	No Change
Differentiate between older and newer options for the management of fatty liver disease patients
Formulate and communicate treatment plans for the management of medically and socially complex patients
Apply best practice strategies to overcome co-morbidities in medically and socially complex patients
Utilize EBM Guidelines for a multitude of conditions that are encountered in primary care
Apply tips and tricks for navigating Epic. (objective used as appropriate)
Utilize Patient Centered Care skill to help patients become better informed and more involved in their health care decisions.

4. Please list additional improvements or changes you plan to make as a result of attending this activity *This question is required.

5. Please list any barriers that you must overcome to implement your planned improvements or changes: 

6. Please REFLECT and relate a circumstance when information you received from a previous Clinical Conference has helped you in your practice

7. What topics would you like covered at future sessions?

8. Was their evidence of commercial bias in this session? 

If yes, please explain

9. 60 year old diabetic obese male presents to your clinic for a wellness exam. Per the AASLD, what is the recommendation regarding screening for NAFLD in this patient?

10. Which of these do not cause hepatic steatosis?

11. You have a 73 yo thin male who presents to clinic with NASH hepatitis. At this time, you want to see if the patient is cirrhotic or has significant changes towards cirrhosis. He refuses to have a liver biopsy. Which of the following is a suitable option for staging of fibrosis?

12. Which of the following is not indicated for treatment of NASH?